Lifeward appoints Ronen Tsimerman as CFO with NIS 70,000 monthly salary
Thời gian đọc: dưới 1 phút
Lifeward appointed Ronen Tsimerman as chief financial officer, effective November 1, 2026, and will enter into an employment agreement with him.
| Individual | Ronen Tsimerman |
| Role | Chief financial officer, principal financial officer and principal accounting officer |
| Type of Change | Appointed; employment agreement to be entered into |
| Effective Date | November 1, 2026 |
| Reason | Not disclosed |
| Background Details | Most recently CFO of Scopio Labs; previously CFO of IceCure Medical, Insuline Medical and Mer-Group divisions, and COO of IceCure Medical. |
| Compensation/Agreement Terms | Subject to shareholder approval of the renewed compensation policy: NIS 70,000 gross monthly base salary, annual performance bonus targeted at no less than four monthly salaries, and a transaction bonus. Three-month termination notice, increasing to four months after a CEO change. |
Original SEC Filing: Lifeward Ltd. [ LFWD ] - 8-K - Oct. 27, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.